CD4 and myeloid sarcoma: Regarding the importance of both oxidative stress and CD4+ T cells in MS pathogenesis, we decided to investigate the oxidant and antioxidant capacity of lymphocytes/CD4+ T cells in RRMS patients, at relapse and remission phases, in comparison to healthy controls.